These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4084335)

  • 1. Cyclosporine in the treatment of intractable polymyositis.
    Goei The HS; Jacobs P; Houben H
    Arthritis Rheum; 1985 Dec; 28(12):1436-7. PubMed ID: 4084335
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine treatment for intractable polymyositis.
    Jones DW; Snaith ML; Isenberg DA
    Arthritis Rheum; 1987 Aug; 30(8):959-60. PubMed ID: 3632739
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine therapy in chronic slowly progressive polymyositis--preliminary report of clinical results in three patients.
    Jongen PJ; Joosten EM; Berden JH; Ter Laak HJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):335-9. PubMed ID: 3381294
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine as monotherapy for polymyositis?
    Borleffs JC
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):333-4. PubMed ID: 3381293
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomyositis/polymyositis.
    Gruhn WB; Diaz-Buxo JA
    J Rheumatol; 1987 Oct; 14(5):1045-7. PubMed ID: 3323505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyositis and cyclosporin A.
    Alijotas J; Barquinero J; Ordi J; Vilardell M
    Ann Rheum Dis; 1990 Jan; 49(1):66. PubMed ID: 2310231
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporin for polymyositis.
    van der Meer S; Imhof JW; Borleffs JC
    Ann Rheum Dis; 1986 Jul; 45(7):612. PubMed ID: 3740986
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporin for polymyositis.
    Bendtzen K; Tvede N; Andersen V; Bendixen G
    Lancet; 1984 Apr; 1(8380):792-3. PubMed ID: 6143105
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of myocarditis and polymyositic heart disease guided by endomyocardial biopsy.
    Mortensen SA; Bendtzen K; Andersen V; Baandrup U
    Concepts Immunopathol; 1989; 7():173-95. PubMed ID: 2676178
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporin in the management of polymyositis and dermatomyositis.
    Lueck CJ; Trend P; Swash M
    J Neurol Neurosurg Psychiatry; 1991 Nov; 54(11):1007-8. PubMed ID: 1800644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent acute myositis after allogeneic bone marrow transplantation for myelodysplasia.
    Sato N; Okamoto S; Mori T; Watanabe R; Hamano Y; Kawamura J; Ishihara D; Ikeda Y
    Hematology; 2002 Apr; 7(2):109-12. PubMed ID: 12186701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A circulating anticoagulant to factor VIII in a patient with polymyositis: successful treatment with azathioprine.
    Corbett AJ; Bell WR; Hochberg MC
    J Rheumatol; 1985 Oct; 12(5):1026-7. PubMed ID: 3936926
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
    Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
    Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of polymyositis in a patient with toxoplasmosis: clinical and pathologic findings and review of literature.
    Adams EM; Hafez GR; Carnes M; Wiesner JK; Graziano FM
    Clin Exp Rheumatol; 1984; 2(3):205-8. PubMed ID: 6529871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Course of dermatomyositis-polymyositis: comparison of untreated and cortisone-treated patients.
    Winkelmann RK; Mulder DW; Lambert EH; Howard FM; Diessner GR
    Mayo Clin Proc; 1968 Aug; 43(8):545-56. PubMed ID: 5711147
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum transaminase in diseases of muscle. Report of a case of polymyositis.
    WARD JA; SMITH EM
    J Med Assoc Ga; 1961 Mar; 50():93-4. PubMed ID: 13783108
    [No Abstract]   [Full Text] [Related]  

  • 17. Survival in polymyositis: corticosteroids and risk factors.
    Carpenter JR; Bunch TW; Engel AG; O'Brien PC
    J Rheumatol; 1977; 4(2):207-14. PubMed ID: 881699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymyositis: a survey of 89 cases with particular reference to treatment and prognosis.
    Rose AL; Walton JN
    Brain; 1966 Dec; 89(4):747-68. PubMed ID: 5958706
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolated elevated aldolase as a marker for a myositis subtype: another branch to the polymyositis tree.
    Hengstman GJ
    J Neurol Neurosurg Psychiatry; 2009 Aug; 80(8):829. PubMed ID: 19608780
    [No Abstract]   [Full Text] [Related]  

  • 20. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.
    Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C
    Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.